» Articles » PMID: 17201158

Curcumin-induced Apoptosis of Human Colon Cancer Colo 205 Cells Through the Production of ROS, Ca2+ and the Activation of Caspase-3

Overview
Journal Anticancer Res
Specialty Oncology
Date 2007 Jan 5
PMID 17201158
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin (diferuloylmethane), the yellow pigment in turmeric (Curcuma longa), is known to inhibit proliferation of cancer cells by arresting them at various phases of the cell cycle and to induce apoptosis in tumor cells. Curcumin-induced apoptosis mainly involves the activation of caspase-3 and mitochondria-mediated pathway in various cancer cells of different tissue origin. In the present study, the induction of apoptosis and cytotoxicity by curcumin in colon cancer colo 205 cells was investigated by using flow cytometry. The results demonstrated that curcumin induced cytotoxicity and apoptosis dose- and time-depedently. Curcumin induced the production of reactive oxygen species (ROS) and Ca+2, decreased the levels of mitochondria membrane potential and induced caspase-3 activity. Curcumin also promoted the expression of Bax, cytochrome C, p53 and p21 but inhibited the expression of Bcl-2. These observations suggest that curcumin may have a possible therapeutic potential in colon cancer patients.

Citing Articles

Targeting the Hippo and Rap1 signaling pathways: the anti-proliferative effects of curcumin in colorectal cancer cell lines.

Sabir D Med Oncol. 2025; 42(2):41.

PMID: 39779534 DOI: 10.1007/s12032-024-02560-w.


Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium Homeostasis.

Jara C, Torres A, Park-Kang H, Sandoval L, Retamal C, Gonzalez A Neurotox Res. 2025; 43(1):3.

PMID: 39775210 DOI: 10.1007/s12640-024-00726-y.


Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer.

Hon K, Naidu R Antioxidants (Basel). 2024; 13(7).

PMID: 39061884 PMC: 11273411. DOI: 10.3390/antiox13070815.


Phytocompounds targeting epigenetic modulations: an assessment in cancer.

Khan A, Khan A, Khan M, Malik Z, Massey S, Parveen R Front Pharmacol. 2024; 14:1273993.

PMID: 38596245 PMC: 11002180. DOI: 10.3389/fphar.2023.1273993.


Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach.

Hon K, Zainal Abidin S, Abas F, Othman I, Naidu R Int J Mol Sci. 2024; 25(6).

PMID: 38542474 PMC: 10970808. DOI: 10.3390/ijms25063503.